Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Medtronic jumps on earnings beat and raised guidance
• U.S. air force striking Iranian targets around the strait of Hormuz, U.S. officials say - Axios